Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement.Session volume stands at 69.3 million versus the average volume of 26.9 million, as per data from Benzinga Pro.Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of$16.23 million. The company reported a second-quarter loss of 41 cents per share, missing estimates for a loss of 34 cents per share.In June, the company streamlined its operating strategy and a ...